je.st
news
Merck settles investor suits on cholesterol drugs
2013-02-14 18:15:13| Biotech - Topix.net
Merck & Co. has agreed to pay $688 million to settle two lawsuits brought by investors who alleged the drugmaker delayed releasing bad news on its blockbuster cholesterol drugs to prevent a drop in sales.
Tags: drugs
investor
suits
cholesterol
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||